(Q44871210)

7 December 2017

title

Prospective association of 25(OH)D with metabolic syndrome (English)

1 reference

7 December 2017

1 reference

6

1 reference

7 December 2017

8

Bernard Zinman

1 reference

7 December 2017

5

Julia A Knight

1 reference

7 December 2017

4

Reinhold Vieth

1 reference

7 December 2017

9

Anthony J Hanley

1 reference

7 December 2017

Sheena Kayaniyil

1

1 reference

7 December 2017

Stewart B Harris

series ordinal

2

1 reference

7 December 2017

Ravi Retnakaran

series ordinal

3

1 reference

7 December 2017

Bruce A Perkins

series ordinal

7

1 reference

7 December 2017

publication date

1 April 2013

1 reference

7 December 2017

published in

Clinical Endocrinology

1 reference

7 December 2017

volume

80

1 reference

7 December 2017

issue

4

1 reference

7 December 2017

page(s)

502-507

1 reference

Serum concentrations of vitamin D and parathyroid hormone and prevalent metabolic syndrome among adults in the United States

7 December 2017

cites work

1 reference

Serum 25-hydroxyvitamin D concentrations in relation to cardiometabolic risk factors and metabolic syndrome in postmenopausal women

21 January 2018

1 reference

25-hydroxyvitamin D, IGF-1, and metabolic syndrome at 45 years of age: a cross-sectional study in the 1958 British Birth Cohort

21 January 2018

1 reference

Association of 25(OH)D and PTH with metabolic syndrome and its traditional and nontraditional components.

21 January 2018

1 reference

Vitamin D intake and status are associated with lower prevalence of metabolic syndrome in U.S. adults: National Health and Nutrition Examination Surveys 2003-2006.

21 January 2018

1 reference

Vitamin D intake is inversely related to risk of developing metabolic syndrome in African American and white men and women over 20 y: the Coronary Artery Risk Development in Young Adults study.

21 January 2018

1 reference

Low serum 25-hydroxyvitamin D is associated with increased risk of the development of the metabolic syndrome at five years: results from a national, population-based prospective study (The Australian Diabetes, Obesity and Lifestyle Study: AusDiab).

21 January 2018

1 reference

Baseline serum 25-hydroxy vitamin d is predictive of future glycemic status and insulin resistance: the Medical Research Council Ely Prospective Study 1990-2000

21 January 2018

1 reference

Parathyroid hormone, but not vitamin D, is associated with the metabolic syndrome in morbidly obese women and men: a cross-sectional study

21 January 2018

1 reference

Vitamin D, parathyroid hormone levels, and the prevalence of metabolic syndrome in community-dwelling older adults.

21 January 2018

1 reference

Vitamin D, PTH, and the metabolic syndrome in severely obese subjects.

21 January 2018

1 reference

Prospective associations of vitamin D with β-cell function and glycemia: the PROspective Metabolism and ISlet cell Evaluation (PROMISE) cohort study

21 January 2018

1 reference

An evaluation of automated methods for measurement of serum 25-hydroxyvitamin D.

21 January 2018

1 reference

Development of questionnaire to examine relationship of physical activity and diabetes in Pima Indians

21 January 2018

1 reference

Harmonizing the metabolic syndrome: a joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; Internat

21 January 2018

1 reference

Evaluation, Treatment, and Prevention of Vitamin D Deficiency: an Endocrine Society Clinical Practice Guideline

21 January 2018

1 reference

Circulating 25-hydroxyvitamin D concentration and the risk of type 2 diabetes: results from the European Prospective Investigation into Cancer (EPIC)-Norfolk cohort and updated meta-analysis of prospective studies

21 January 2018

1 reference

Serum 25-hydroxyvitamin D, calcium intake, and risk of type 2 diabetes after 5 years: results from a national, population-based prospective study (the Australian Diabetes, Obesity and Lifestyle study)

21 January 2018

1 reference

Association of vitamin D with insulin resistance and beta-cell dysfunction in subjects at risk for type 2 diabetes

21 January 2018

1 reference

Vitamin D3 and the risk of CVD in overweight and obese women: a randomised controlled trial.

21 January 2018

1 reference

No improvement in cardiovascular risk factors in overweight and obese subjects after supplementation with vitamin D3 for 1 year

21 January 2018

1 reference

No effect of supplementation with cholecalciferol on cytokines and markers of inflammation in overweight and obese subjects.

21 January 2018

1 reference

Improvement of vitamin D status resulted in amelioration of biomarkers of systemic inflammation in the subjects with type 2 diabetes

21 January 2018

1 reference

Vitamin D Status and Changes in Cardiovascular Risk Factors: A Prospective Study of a General Population

21 January 2018

1 reference

The association of serum vitamin D level with presence of metabolic syndrome and hypertension in middle-aged Korean subjects

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1111/CEN.12190

1 reference

7 December 2017

1 reference